Kuen‐Daw Tsai

821 citations

20 papers · 678 indexed · h-index 13

Molecular Biology
Plant Science
Immunology
Pharmacology top 10%
Complementary and alternative medicine top 10%

Co-authors: Wen‐Huang Peng Shih‐Lan Hsu Chiu-Yuan Chen Jaw‐Ming Cherng Shumei Yang Min‐Jen Tseng Yi‐Ju Lee Jung‐Chung Lin
Topics: Bioactive Compounds and Antitumor Agents (5 papers)Cancer therapeutics and mechanisms (5 papers)Cell death mechanisms and regulation (5 papers)
Cited by: Biochemistry Pharmacology Complementary and alternative medicine
Journals: Cancer Research Nutrients Life Sciences
Partner nations: Taiwan Poland United States

In The Last Decade

Kuen‐Daw Tsai

20 papers receiving 661 citations

Peers

Countries citing papers authored by Kuen‐Daw Tsai

Since Specialization

Citations

This map shows the geographic impact of Kuen‐Daw Tsai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kuen‐Daw Tsai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kuen‐Daw Tsai more than expected).

Fields of papers citing papers by Kuen‐Daw Tsai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kuen‐Daw Tsai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kuen‐Daw Tsai. The network helps show where Kuen‐Daw Tsai may publish in the future.

Co-authorship network of co-authors of Kuen‐Daw Tsai

This figure shows the co-authorship network connecting the top 25 collaborators of Kuen‐Daw Tsai. A scholar is included among the top collaborators of Kuen‐Daw Tsai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kuen‐Daw Tsai. Kuen‐Daw Tsai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Recombinant Klotho attenuates IFNγ receptor signaling and SAMHD1 expression through blocking NF-κB translocation in glomerular mesangial cells 2023 ·International Journal of Medical Sciences ·Kuen‐Daw Tsai,Yi‐Chao Lee,Boyu Chen,(unknown),(unknown),Mingyuan Liu,Yu‐Wen Hung,H. F. Hsü,(unknown),Jia‐Ching Shieh,Yi‐Ju Lee,Ting‐Hui Lin	2
2	Generalist versus specialist nurses’ knowledge, attitudes, and behavioral intentions toward promoting pulmonary rehabilitation for patients with chronic obstructive pulmonary disease 2018 ·Medicine ·Su‐Er Guo,(unknown),Chizimuzo T.C. Okoli,(unknown),Kuen‐Daw Tsai,Ming‐Shian Lin,Hsin‐Tien Hsu	29
3	Upregulation of PRMT6 by LPS suppresses Klotho expression through interaction with NF‐κB in glomerular mesangial cells 2017 ·Journal of Cellular Biochemistry ·Kuen‐Daw Tsai,(unknown),Wei Chen,Bo‐Yu Chen,(unknown),(unknown),Sue‐Hong Wang,Yi‐Ju Lee,(unknown),Jia‐Ching Shieh,Ting‐Hui Lin	15
4	Molecular Mechanism of Cinnamomum verum Component Cuminaldehyde Inhibits Cell Growth and Induces Cell Death in Human Lung Squamous Cell Carcinoma NCI-H520 Cells In Vitro and In Vivo 2016 ·Journal of Cancer ·Shumei Yang,Kuen‐Daw Tsai,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Jaw‐Ming Cherng	21
5	Discovery of a Novel Anti-Cancer Agent Targeting Both Topoisomerase I & II as Well as Telomerase Activities in Human Lung Adenocarcinoma A549 Cells In Vitro and In Vivo: Cinnamomum verum Component Cuminaldehyde 2016 ·Current Cancer Drug Targets ·(unknown),Kuen‐Daw Tsai,Shumei Yang,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Jaw‐Ming Cherng	12
6	Cuminaldehyde from Cinnamomum verum Induces Cell Death through Targeting Topoisomerase 1 and 2 in Human Colorectal Adenocarcinoma COLO 205 Cells 2016 ·Nutrients ·Kuen‐Daw Tsai,(unknown),(unknown),Shumei Yang,(unknown),(unknown),(unknown),Jaw‐Ming Cherng	40
7	Cinnamomum verum ingredient 2-methoxycinnamaldehyde: a new antiproliferative drug targeting topoisomerase I and II in human lung squamous cell carcinoma NCI-H520 cells 2016 ·European Journal of Cancer Prevention ·(unknown),Kuen‐Daw Tsai,Shumei Yang,(unknown),(unknown),(unknown),Jaw‐Ming Cherng	11
8	Cinnamomum verum component 2-methoxycinnamaldehyde: a novel antiproliferative drug inducing cell death through targeting both topoisomerase I and II in human colorectal adenocarcinoma COLO 205 cells 2016 ·Food & Nutrition Research ·Kuen‐Daw Tsai,(unknown),(unknown),(unknown),(unknown),Shumei Yang,(unknown),Jaw‐Ming Cherng	12
9	Cinnamomum verumComponent 2-Methoxycinnamaldehyde: A Novel Anticancer Agent with Both Anti-Topoisomerase I and II Activities in Human Lung Adenocarcinoma A549 CellsIn VitroandIn Vivo 2015 ·Phytotherapy Research ·(unknown),Kuen‐Daw Tsai,(unknown),Shumei Yang,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Jaw‐Ming Cherng	21
10	Downregulation of connective tissue growth factor by LPS/IFN-γ-induced nitric oxide is reversed by aristolochic acid treatment in glomerular mesangial cells via STAT-1α and NF-κB signaling 2014 ·Chemico-Biological Interactions ·Kuen‐Daw Tsai,Wei Chen,Sue‐Hong Wang,(unknown),(unknown),(unknown),Yi‐Ju Lee,(unknown),Min‐Jen Tseng,Ting‐Hui Lin	11
11	Differential effects of LY294002 and wortmannin on inducible nitric oxide synthase expression in glomerular mesangial cells 2012 ·International Immunopharmacology ·Kuen‐Daw Tsai,Wen‐Wei Chang,Chia-Ching Lin,Shu‐Ching Hsu,Yi‐Ju Lee,Wei Chen,Jia‐Ching Shieh,Ting‐Hui Lin	8
12	Curcumin Protects against UVB-Induced Skin Cancers in SKH-1 Hairless Mouse: Analysis of Early Molecular Markers in Carcinogenesis 2012 ·Evidence-based Complementary and Alternative Medicine ·Kuen‐Daw Tsai,(unknown),Shumei Yang,Min‐Jen Tseng,Jeng‐Dong Hsu,Yi‐Ju Lee,Jaw‐Ming Cherng	41
13	Targeted Methylation of Two Tumor Suppressor Genes Is Sufficient to Transform Mesenchymal Stem Cells into Cancer Stem/Initiating Cells 2011 ·Cancer Research ·(unknown),Pei‐Chi Hou,Kuan‐Der Lee,Pei‐Yi Chu,Kun‐Tu Yeh,Victor X. Jin,Min‐Jen Tseng,Shaw‐Jenq Tsai,Yu‐Sun Chang,Chi‐Sheng Wu,H. Sunny Sun,Kuen‐Daw Tsai,Long‐Bin Jeng,Kenneth P. Nephew,Tim H-M. Huang,Shu‐Huei Hsiao,Yu‐Wei Leu	79
14	Molecular Mechanisms Underlying Chemopreventive Activities of Glycyrrhizic Acid against UVB-Radiation-Induced Carcinogenesis in SKH-1 Hairless Mouse Epidermis 2011 ·Radiation Research ·Jaw‐Ming Cherng,Kuen‐Daw Tsai,(unknown),Jung‐Chung Lin	35
15	Diallyl sulfide protects against ultraviolet B‐induced skin cancers in SKH‐1 hairless mouse: analysis of early molecular events in carcinogenesis 2011 ·Photodermatology Photoimmunology & Photomedicine ·Jaw‐Ming Cherng,Kuen‐Daw Tsai,Daw‐Shyong Perng,(unknown),James Cheng‐Chung Wei,Jung‐Chung Lin	14
16	Panax notoginseng Attenuates Bleomycin‐Induced Pulmonary Fibrosis in Mice 2011 ·Evidence-based Complementary and Alternative Medicine ·Kuen‐Daw Tsai,Shumei Yang,(unknown),(unknown),(unknown),Ting‐Hui Lin,Min‐Jen Tseng,Wei Chen	15
17	Role of Gallium-67 scintigraphy in the evaluation of occult sepsis in the medical ICU 2011 ·Internal and Emergency Medicine ·Wei‐Chun Chen,Kuen‐Daw Tsai,Chia‐Hung Chen,Ming‐Shian Lin,Chuan‐Mu Chen,Chuen‐Ming Shih,Wei Chen	13
18	The fungal metabolite, citrinin, inhibits lipopolysaccharide/interferon-γ-induced nitric oxide production in glomerular mesangial cells 2010 ·International Immunopharmacology ·Biing-Hui Liu,(unknown),(unknown),Kuen‐Daw Tsai,Yi‐Ju Lee,Chia-Ching Lin,Shu‐Ching Hsu,Shumei Yang,Ting‐Hui Lin	13
19	An Assessment of Patient Safety in Acupuncture Process Under EMR Support 2010 ·Journal of Medical Systems ·Yi‐Chang Li,Ming-Chien Hung,(unknown),Kuen‐Daw Tsai,(unknown)	5
20	Luteolin suppresses inflammation-associated gene expression by blocking NF-κB and AP-1 activation pathway in mouse alveolar macrophages 2007 ·Life Sciences ·Chiu-Yuan Chen,Wen‐Huang Peng,Kuen‐Daw Tsai,Shih‐Lan Hsu	281

About Kuen‐Daw Tsai

Kuen‐Daw Tsai is a scholar working on Toxicology, Issues, ethics and legal aspects and Pharmacology, having authored 20 papers that have together received 678 indexed citations. Recurring topics across this work include Bioactive Compounds and Antitumor Agents (5 papers), Cancer therapeutics and mechanisms (5 papers) and Cell death mechanisms and regulation (5 papers). The work is most often cited by research in Biochemistry (60 citations), Pharmacology (76 citations) and Complementary and alternative medicine (68 citations). Kuen‐Daw Tsai has collaborated with scholars based in Taiwan, Poland and United States. Frequent co-authors include Wen‐Huang Peng, Shih‐Lan Hsu, Chiu-Yuan Chen, Jaw‐Ming Cherng, Shumei Yang, Min‐Jen Tseng, Yi‐Ju Lee, Jung‐Chung Lin, Ting‐Hui Lin and Ming‐Shian Lin. Their work appears in journals such as Cancer Research, Nutrients and Life Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact